e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Clinical physiology and functional imaging in health and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Low lung volume is associated with visceral adipose tissue inflammation
S. Kawase, M. Takaoka, S. Miyamoto, H. Ohnishi, T. Kubota, T. Namikawa, K. Hanazaki, A. Yokoyama (Nankoku, Japan)
Source:
Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Session:
Clinical physiology and functional imaging in health and disease
Session type:
Poster Discussion
Number:
3428
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Kawase, M. Takaoka, S. Miyamoto, H. Ohnishi, T. Kubota, T. Namikawa, K. Hanazaki, A. Yokoyama (Nankoku, Japan). Low lung volume is associated with visceral adipose tissue inflammation. Eur Respir J 2013; 42: Suppl. 57, 3428
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
LATE-BREAKING ABSTRACT: Mast cell markers in adipose tissue, systemic inflammation and asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Adipokines in end-stage lung diseases: The crosstalk between bone and adipose tissue
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Characterisation of adipose tissue macrophage phenotypes in obese asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Metabolic syndrome and visceral adipose tissue (VAT) are associated with obstructive and restrictive lung function impairment.
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020
Lung function impairment in adult asthma increases the risk of systemic inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Presence of progranulin in airway inflammation associated with COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Different response of lung tissue to intravenous acetylated opium
Source: International Congress 2015 – Different data in COPD
Year: 2015
Evaluation of the role of inflammation in chronic airways disease (ERICA): Midpoint evaluation
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Metalloproteases gene expression and remodeling of lung parenchyma fibers during the progression of elastase induced emphysema
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Scleroderma lung disease: A scleroderma physiologic index (SPI) derived from lung physiology and oxygen saturation
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Chemical exposure triggering connective tissue disease with lung involvement
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015
A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016
Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders
Source: International Congress 2014 – IPF and surroundings
Year: 2014
The effects of mesechymal cells isolated from abdominal adipose tissue on rat model of emphysema
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept